Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study

Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study

Creatinine-based estimated glomerular filtration rate (eGFR) determines chronic kidney disease (CKD) stage, but underestimates renal function. The 2014 updated guidance from the National Institute for Health and Care Excellence (NICE) recommends that GPs reduce overdiagnosis of CKD stage 3a (eGFR 45...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Lasserson, D, Shine, B, O'Callaghan, C, James, T
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Royal College of General Practitioners 2017

Παρόμοια τεκμήρια

Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
ανά: O'Callaghan, C, κ.ά.
Έκδοση: (2011)

Cystatin C proteoforms in chronic kidney disease.
ανά: Helene Dahl, κ.ά.
Έκδοση: (2023-01-01)

Cystatin C proteoforms in chronic kidney disease
ανά: Helene Dahl, κ.ά.
Έκδοση: (2023-01-01)

Chronic kidney disease--assessing the impact.
ανά: O'Callaghan, C
Έκδοση: (2009)

Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients
ανά: Marlene Tapper, κ.ά.
Έκδοση: (2021-01-01)

Cystatin C as a Predictor of Mortality and Cardiovascular Events in a Population with Chronic Kidney Disease
ανά: Ana Vigil, κ.ά.
Έκδοση: (2014-01-01)

Prevalence of chronic kidney disease in the community in the United Kingdom in OxRen, a population-based cohort study
ανά: Hirst, J, κ.ά.
Έκδοση: (2020)

Global prevalence of chronic kidney disease - a systematic review and meta-analysis
ανά: Hill, N, κ.ά.
Έκδοση: (2016)

Global prevalence of chronic kidney disease: A systematic review and meta-analysis
ανά: Hill, N, κ.ά.
Έκδοση: (2016)

Determination of Cystatin C Level in a Sample of Patients with Chronic Kidney Disease
ανά: Maryam Noman Salman, κ.ά.
Έκδοση: (2022-11-01)

Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
ανά: Chee Wai Wong, κ.ά.
Έκδοση: (2015-01-01)

Serum Cystatin C in Chronic Kidney Disease: A Case-Control Study
ανά: Sukanya Shetty, κ.ά.
Έκδοση: (2021-12-01)

Creatinine- and Cystatin C-Based Incidence of Chronic Kidney Disease and Acute Kidney Disease in AKI Survivors
ανά: Claire Rimes-Stigare, κ.ά.
Έκδοση: (2018-01-01)

The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK
ανά: Hill, N, κ.ά.
Έκδοση: (2013)

FORM-2C (Frequency of Renal Monitoring – Creatinine and Cystatin C): an observational cohort study of primary care patients with reduced eGFR
ανά: Fleming, S, κ.ά.
Έκδοση: (2021)

Reduced kidney function at presentation in unselected acute emergency medical admissions : incidence, outcome and associated factors
ανά: Yang, E, κ.ά.
Έκδοση: (2019)

The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City
ανά: Mohammed Khalid J. Al-Nori, κ.ά.
Έκδοση: (2019-06-01)

Comparison of the association intensity of creatinine and cystatin C with hyperphosphatemia and hyperparathyroidism in patients with chronic kidney disease
ανά: Byungju Min, κ.ά.
Έκδοση: (2023-03-01)

Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
ανά: M P Vasilyeva, κ.ά.
Έκδοση: (2015-06-01)

A systematic review and metaanalysis comparing the bias and accuracy of the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations in community-based populations
ανά: McFadden, E, κ.ά.
Έκδοση: (2018)

Association between severe chronic kidney disease defined by cystatin-c and creatinine and clinical outcomes in an elderly population - an observational study
ανά: Joana Tavares, κ.ά.

Statistical models for the deterioration of kidney function in a primary care population: a retrospective database analysis
ανά: Oke, JL, κ.ά.
Έκδοση: (2019)

Cystatin C and collagen type IV in diagnostics of chronic kidney disease in type 2 diabetic patients
ανά: Vadim Valer'evich Klimontov, κ.ά.
Έκδοση: (2015-03-01)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
ανά: Jung Nam An, κ.ά.
Έκδοση: (2022-09-01)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
ανά: Young Youl Hyun, κ.ά.
Έκδοση: (2022-09-01)

Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease
ανά: Leila Abid, κ.ά.
Έκδοση: (2016-07-01)

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C
ανά: Elles M. Screever, κ.ά.
Έκδοση: (2021-09-01)

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.
ανά: Nathan R Hill, κ.ά.
Έκδοση: (2016-01-01)

Cystatin C: diagnostic and prognostic value in acute kidney injury
ανά: D. I. Korabelnikov, κ.ά.
Έκδοση: (2024-08-01)

Cystatin C in Alzheimer’s disease
ανά: Efrat eLevy
Έκδοση: (2012-07-01)

Cystatin C as a Marker of Kidney Function in Children
ανά: Megan Skidmore, κ.ά.
Έκδοση: (2024-08-01)

Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease
ανά: Yu-Li Lin, κ.ά.
Έκδοση: (2021-08-01)

A Comparison of Serum Cystatin C and Creatinine with Glomerular FiltrationRate in Indian Patients with Chronic Kidney Disease
ανά: Ramanathan Kumaresan, κ.ά.
Έκδοση: (2011-11-01)

Cystatin C and renal function in pediatric kidney transplant recipients
ανά: M.C.P. Franco, κ.ά.
Έκδοση: (2009-12-01)

Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
ανά: Nana Wang, κ.ά.
Έκδοση: (2022-05-01)

Rapid Conductometric Sensing of Chronic Kidney Disease Biomarkers: Specific and Precise Detection of Creatinine and Cystatin C in Artificial Saliva
ανά: Mingjie Yang, κ.ά.
Έκδοση: (2024-11-01)

Comparison of glomerular filtration rates calculated by different serum cystatin C-based equations in patients with chronic kidney disease
ανά: Hee Sun Lee, κ.ά.
Έκδοση: (2014-03-01)

Clinical Utility of Serum Cystatin C in Comparison with Serum Creatinine, Urea and Uric Acid in Patients with Chronic Kidney Disease
ανά: Anu C John, κ.ά.
Έκδοση: (2020-07-01)

Stroke risk markers of blood pressure variability: associations with Chronic Kidney Disease (CKD) and identification in primary care
ανά: Lasserson, D, κ.ά.
Έκδοση: (2013)

Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD
ανά: Feakins, B, κ.ά.
Έκδοση: (2019)